ClinConnect ClinConnect Logo
Search / Trial NCT03806881

Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant

Launched by MATERIALISE · Jan 15, 2019

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

The Glenius glenoid implant is a solution for patients who need a reversed glenoid reconstruction (primary or revision) because of a severely damaged glenoid associated with severe bone loss. In these cases, standard reconstruction of the glenoid is not possible because of the lack of body support of the glenoid rim or columns.

The Glenius implant is custom-made prothesis: during pre-operative planning, the implant is designed based on a detailed 3D CT analysis of the defect with special reference to bone quality and the anatomy of the bone deficient glenoid. Optimized screw fixation traje...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients having primary or revision shoulder joint replacement with severe glenoid bone defects
  • Patient is 18 years of age or older
  • Patient can follow the Glenius system procedure that is standard of care
  • Patient is willing to cooperate in the required post-operative therapy
  • Patient has participated in the informed consent process and has signed the EC approved informed consent form
  • Exclusion Criteria:
  • Pregnant patients
  • Skeletally immature patients
  • Prisoners

About Materialise

Materialise is a leading global provider of 3D printing solutions and medical software, dedicated to advancing the field of personalized healthcare through innovative technologies. With a strong emphasis on research and development, Materialise collaborates with healthcare professionals and institutions to enhance patient outcomes by offering cutting-edge tools for surgical planning, medical device development, and custom implants. Their commitment to quality and precision in the clinical trial process ensures that new therapeutic approaches are rigorously evaluated, paving the way for breakthroughs in patient care and treatment efficacy.

Locations

Herentals, , Belgium

Leuven, , Belgium

Leuven, , Belgium

Delft, , Netherlands

Nijmegen, , Netherlands

Leuven, , Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials